The mode of action of polyketoacidomycin on Bacillus subtilis.
D000900:Anti-Bacterial Agents / Q000494:pharmacology*; D001412:Bacillus subtilis / Q000187:drug effects* / Q000378:metabolism; D002308:Cardiolipins / Q000096:biosynthesis; D002463:Cell Membrane Permeability / Q000187:drug effects*; D004269:DNA, Bacterial / Q000378:metabolism; D005227:Fatty Acids / Q000096:biosynthesis; D005994:Glycerophosphates / Q000096:biosynthesis; D010743:Phospholipids / Q000378:metabolism; D011188:Potassium / Q000378:metabolism; D012329:RNA, Bacterial / Q000378:metabolism; D012964:Sodium / Q000378:metabolism
D000900:Anti-Bacterial Agents; D002308:Cardiolipins; D004269:DNA, Bacterial; D005227:Fatty Acids; D005994:Glycerophosphates; D010743:Phospholipids; D012329:RNA, Bacterial; D012964:Sodium; D011188:Potassium